Brief: Marksans Pharma Says UK MHRA Grants Marketing Authorisation For Loratadine Oral Solution
05/02/2019 09:11
Feb 5 (Reuters) - Marksans Pharma Ltd MARK.NS :
* ANNOUNCES UK MHRA GRANT OF MARKETING AUTHORISATION FOR
LORATADINE 5MG/5ML ORAL SOLUTION
* SAYS PRODUCT WILL BE MANUFACTURED IN ITS UK FACILITY
Source text - http://bit.ly/2ScvhUu
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg